SCHEMBL20894612

SCHEMBL20894612

Clc1cc(-c2cccc(C(=C(c3ccccc3)c3ccccc3)c3ccccc3)c2)cc(-c2nc3ccccc3s2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 8/20 0.51
▸ SMN1; SMN2 Q16637 5/20 0.51
▸ NFKB1 P19838 4/20 0.51
▸ NFKB2 Q00653 4/20 0.51
▸ RELA Q04206 4/20 0.51
▸ LMNA P02545 4/20 0.51
▸ TP53 P04637 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ RXRA P19793 1/20 0.49
▸ RXRB P28702 1/20 0.49
▸ MAPT P10636 8/20 0.48
▸ KDM4E B2RXH2 7/20 0.48
▸ NPC1 O15118 5/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MMP2 P08253 1/20 0.47
▸ MMP9 P14780 1/20 0.47
▸ MMP8 P22894 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319434 0.94 RAB9A (0.57) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL20894815 0.89 RAB9A (0.52) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL22466378 0.87 RAB9A (0.66) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL26536355 0.86 RAB9A (0.60) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24557199 0.83 KDM4E (0.59) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24332039 0.81 RAB9A (0.64) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL26536350 0.80 RAB9A (0.63) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL26536353 0.80 RAB9A (0.63) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL20903527 0.80 RAB9A (0.50) RAB9ASMN1; SMN2NFKB1NFKB2RELA
SCHEMBL20894573 0.80 SNCA (0.44) RAB9ASMN1; SMN2NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470398-B1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER NOVALED GMBH (DE) 2022-05-04 — — EP disclosed
EP-3470398-B1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER NOVALED GMBH (DE) 2022-05-04 — — EP disclosed
US-20200317704-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer NOVALED GMBH (DE) 2020-10-08 — — US disclosed
US-20200317704-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer NOVALED GMBH (DE) 2020-10-08 — — US disclosed
WO-2019072932-A1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER NOVALED GMBH (DE) 2019-04-18 — — WO disclosed
WO-2019072932-A1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER NOVALED GMBH (DE) 2019-04-18 — — WO disclosed
EP-3470398-A1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER Novaled GmbH (DE) 2019-04-17 — — EP disclosed
EP-3470398-A1 ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER Novaled GmbH (DE) 2019-04-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200317704-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer SELE, EPCAM, OR51E2 RAB9A 3011/4885SMN1; SMN2 3935/4885NFKB1 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback